Related Experiment Video
Updated: Jun 1, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Post-translational modifications and bronchopulmonary dysplasia
1Department of Neonatology, Children's Medical Center, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Insights
Protein post-translational modifications influence bronchopulmonary dysplasia (BPD) development. Understanding these modifications offers new therapeutic targets for this infant respiratory disorder.
Area of Science:
- Biochemistry
- Molecular Biology
- Neonatology
Background:
- Bronchopulmonary dysplasia (BPD) is a major respiratory complication in premature infants.
- Limited therapeutic options exist for BPD, necessitating a deeper understanding of its pathogenesis.
- Protein post-translational modifications (PTMs) are crucial regulators of cellular functions and protein diversity.
Purpose of the Study:
- To review the role of various PTMs in the molecular mechanisms of BPD.
- To explore the connection between specific PTMs and BPD pathogenesis.
- To identify potential therapeutic targets for BPD based on PTMs.
Main Methods:
- Literature review focusing on PTMs and BPD.
- Analysis of signaling pathways affected by PTMs in BPD.
- Synthesis of current evidence linking PTMs to BPD progression.
Main Results:
- PTMs like phosphorylation, acetylation, ubiquitination, SUMOylation, methylation, glycosylation, glycation, S-glutathionylation, and S-nitrosylation are linked to BPD.
- These modifications contribute to BPD pathogenesis via complex signal transduction cascades.
- Evidence suggests PTMs significantly impact cellular processes relevant to BPD.
Conclusions:
- PTMs are integral to the molecular pathogenesis of bronchopulmonary dysplasia.
- Targeting specific protein PTMs presents a promising avenue for novel BPD therapies.
- Further research into PTMs could revolutionize the clinical management of BPD.
Abstract:
Bronchopulmonary dysplasia is a prevalent respiratory disorder posing a significant threat to the quality of life in premature infants. Its pathogenesis is intricate, and therapeutic options are limited. Besides genetic coding, protein post-translational modification plays a pivotal role in regulating cellular function, contributing complexity and diversity to substrate proteins and influencing various cellular processes. Substantial evidence indicates that post-translational modifications of several substrate proteins are intricately related to the molecular mechanisms underlying bronchopulmonary dysplasia. These modifications facilitate the progression of bronchopulmonary dysplasia through a cascade of signal transduction events. This review outlines the relationships between substrate protein phosphorylation, acetylation, ubiquitination, SUMOylation, methylation, glycosylation, glycation, S-glutathionylation, S-nitrosylation and bronchopulmonary dysplasia. The aim is to provide novel insights into bronchopulmonary dysplasia's pathogenesis and potential therapeutic targets for clinical management.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Pulmonary Cycle: Exhalation
Breathing
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

